Stericycle (NASDAQ:SRCL) Research Coverage Started at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCL) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the business services provider’s stock.

Several other equities analysts also recently weighed in on the company. Truist Financial boosted their target price on Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research report on Tuesday, June 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods upped their price objective on Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $74.00.

Stericycle Stock Performance

NASDAQ SRCL opened at $61.68 on Tuesday. The company has a market cap of $5.73 billion, a P/E ratio of -280.36, a P/E/G ratio of 3.37 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13. The business’s 50 day moving average price is $59.06 and its 200-day moving average price is $54.62. Stericycle has a fifty-two week low of $37.78 and a fifty-two week high of $61.77.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.04. The firm had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. Sell-side analysts predict that Stericycle will post 2.29 earnings per share for the current year.

Hedge Funds Weigh In On Stericycle

Hedge funds have recently bought and sold shares of the business. Clearstead Trust LLC bought a new position in shares of Stericycle during the 1st quarter worth $25,000. Principal Securities Inc. purchased a new position in shares of Stericycle during the fourth quarter valued at $41,000. GAMMA Investing LLC increased its stake in shares of Stericycle by 170.9% during the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after buying an additional 516 shares during the period. TFO Wealth Partners LLC increased its stake in shares of Stericycle by 22,325.0% during the fourth quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock valued at $44,000 after buying an additional 893 shares during the period. Finally, Headlands Technologies LLC purchased a new position in shares of Stericycle during the first quarter valued at $44,000. Institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.